Global Left Atrial Appendage Closure (LAAC) Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Left Atrial Appendage Closure (LAAC) Device market size was valued at US$ 1110 million in 2024 and is forecast to a readjusted size of USD 1438 million by 2031 with a CAGR of 3.8% during review period.

A Left Atrial Appendage Closure (LAAC) device is a medical device designed to close off the left atrial appendage (LAA), which is a small, ear-shaped pouch in the left atrium of the heart. The LAA is known to be a common site for the formation of blood clots, especially in patients with atrial fibrillation (a type of irregular heartbeat). These blood clots can increase the risk of stroke if they dislodge and travel to the brain.

Clinical studies and data were being generated to demonstrate the long-term efficacy and safety of LAAC devices. This growing body of evidence was expected to influence clinical practice guidelines and support broader adoption.

This report is a detailed and comprehensive analysis for global Left Atrial Appendage Closure (LAAC) Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Left Atrial Appendage Closure (LAAC) Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Left Atrial Appendage Closure (LAAC) Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Left Atrial Appendage Closure (LAAC) Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Left Atrial Appendage Closure (LAAC) Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Left Atrial Appendage Closure (LAAC) Device

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Left Atrial Appendage Closure (LAAC) Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Abbott, AtriCure, Cardia, Johnson & Johnson, Lifetech Scientific, Occlutech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Left Atrial Appendage Closure (LAAC) Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Endocardial LAAC Devices
Epicardial LAAC Devices

Market segment by Application
Hospital
Ambulatory Surgical Centers
Others

Major players covered
Boston Scientific
Abbott
AtriCure
Cardia
Johnson & Johnson
Lifetech Scientific
Occlutech

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Left Atrial Appendage Closure (LAAC) Device product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Left Atrial Appendage Closure (LAAC) Device, with price, sales quantity, revenue, and global market share of Left Atrial Appendage Closure (LAAC) Device from 2020 to 2025.

Chapter 3, the Left Atrial Appendage Closure (LAAC) Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Left Atrial Appendage Closure (LAAC) Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Left Atrial Appendage Closure (LAAC) Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Left Atrial Appendage Closure (LAAC) Device.

Chapter 14 and 15, to describe Left Atrial Appendage Closure (LAAC) Device sales channel, distributors, customers, research findings and conclusion.